Zymeworks Inc. Common Shares (ZYME): Price and Financial Metrics
ZYME Price/Volume Stats
| Current price | $14.14 | 52-week high | $17.70 |
| Prev. close | $13.58 | 52-week low | $7.97 |
| Day low | $13.11 | Volume | 1,608,500 |
| Day high | $14.15 | Avg. volume | 613,148 |
| 50-day MA | $14.17 | Dividend yield | N/A |
| 200-day MA | $11.13 | Market Cap | 973.93M |
ZYME Stock Price Chart Interactive Chart >
Zymeworks Inc. Common Shares (ZYME) Company Bio
Zymeworks Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The company was founded in 2003 and is based in Vancouver, BC.
ZYME Price Returns
| 1-mo | 3.36% |
| 3-mo | 8.02% |
| 6-mo | 68.33% |
| 1-year | 43.85% |
| 3-year | -14.82% |
| 5-year | -68.60% |
| YTD | 36.09% |
| 2023 | 32.19% |
| 2022 | -52.04% |
| 2021 | -65.32% |
| 2020 | 3.96% |
| 2019 | 209.67% |
Continue Researching ZYME
Here are a few links from around the web to help you further your research on Zymeworks Inc's stock as an investment opportunity:Zymeworks Inc (ZYME) Stock Price | Nasdaq
Zymeworks Inc (ZYME) Stock Quote, History and News - Yahoo Finance
Zymeworks Inc (ZYME) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...